Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival

Henk M. Lokhorst; Bronno Van Der Holt; Jan J. Cornelissen; Marie José Kersten; Marinus Van Oers; Reinier  Raijmakers; Monique C. Minnema; Sonja Zweegman; Gerard Bos; Nicolaas Schaap; Shulamiet Wittebol; Okke de Weerdt; Rianne Ammerlaan; Pieter Sonneveld

doi:10.3324/haematol.2015.128728

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival

Henk M. Lokhorst^*
, Bronno Van Der Holt
, Jan J. Cornelissen
, Marie José Kersten
, Marinus Van Oers
, Reinier Raijmakers
, Monique C. Minnema
, Sonja Zweegman
, Gerard Bos
, Nicolaas Schaap
, Shulamiet Wittebol
, Okke de Weerdt
, Rianne Ammerlaan
, Pieter Sonneveld

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	e508-e510
Journal	Haematologica
Volume	100
Issue number	12
DOIs	https://doi.org/10.3324/haematol.2015.128728
Publication status	Published - 2015

Keywords

Allogeneic stem cell transplantation
Myeloma
Prognosis

Access to Document

10.3324/haematol.2015.128728

Cite this

Lokhorst, H. M., Van Der Holt, B., Cornelissen, J. J., Kersten, M. J., Van Oers, M., Raijmakers, R., Minnema, M. C., Zweegman, S., Bos, G., Schaap, N., Wittebol, S., de Weerdt, O., Ammerlaan, R., & Sonneveld, P. (2015). Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. Haematologica, 100(12), e508-e510. https://doi.org/10.3324/haematol.2015.128728

@article{93232669a85c40568991903197970d21,

title = "Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival",

keywords = "Allogeneic stem cell transplantation, Myeloma, Prognosis",

author = "Lokhorst, \{Henk M.\} and \{Van Der Holt\}, Bronno and Cornelissen, \{Jan J.\} and Kersten, \{Marie Jos{\'e}\} and \{Van Oers\}, Marinus and Reinier Raijmakers and Minnema, \{Monique C.\} and Sonja Zweegman and Gerard Bos and Nicolaas Schaap and Shulamiet Wittebol and \{de Weerdt\}, Okke and Rianne Ammerlaan and Pieter Sonneveld",

year = "2015",

doi = "10.3324/haematol.2015.128728",

language = "English",

volume = "100",

pages = "e508--e510",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "12",

}

Lokhorst, HM, Van Der Holt, B, Cornelissen, JJ, Kersten, MJ, Van Oers, M, Raijmakers, R , Minnema, MC, Zweegman, S, Bos, G, Schaap, N, Wittebol, S, de Weerdt, O, Ammerlaan, R & Sonneveld, P 2015, 'Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival', Haematologica, vol. 100, no. 12, pp. e508-e510. https://doi.org/10.3324/haematol.2015.128728

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. / Lokhorst, Henk M.; Van Der Holt, Bronno; Cornelissen, Jan J. et al.
In: Haematologica, Vol. 100, No. 12, 2015, p. e508-e510.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival

AU - Lokhorst, Henk M.

AU - Van Der Holt, Bronno

AU - Cornelissen, Jan J.

AU - Kersten, Marie José

AU - Van Oers, Marinus

AU - Raijmakers, Reinier

AU - Minnema, Monique C.

AU - Zweegman, Sonja

AU - Bos, Gerard

AU - Schaap, Nicolaas

AU - Wittebol, Shulamiet

AU - de Weerdt, Okke

AU - Ammerlaan, Rianne

AU - Sonneveld, Pieter

PY - 2015

Y1 - 2015

KW - Allogeneic stem cell transplantation

KW - Myeloma

KW - Prognosis

UR - https://www.scopus.com/pages/publications/84948950800

U2 - 10.3324/haematol.2015.128728

DO - 10.3324/haematol.2015.128728

M3 - Article

C2 - 26341740

AN - SCOPUS:84948950800

SN - 0390-6078

VL - 100

SP - e508-e510

JO - Haematologica

JF - Haematologica

IS - 12

ER -

Lokhorst HM, Van Der Holt B, Cornelissen JJ, Kersten MJ, Van Oers M, Raijmakers R et al. Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. Haematologica. 2015;100(12):e508-e510. doi: 10.3324/haematol.2015.128728

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival

Keywords

Access to Document

Other files and links

Cite this